Generic placeholder image

Recent Patents on CNS Drug Discovery (Discontinued)


ISSN (Print): 1574-8898
ISSN (Online): 2212-3954

Therapeutic Approach of Histamine H3 Receptors in Obesity

Author(s): Takayuki Masaki and Hironobu Yoshimatsu

Volume 2, Issue 3, 2007

Page: [238 - 240] Pages: 3

DOI: 10.2174/157488907782411792

Price: $65


Obesity is considered one of the risk factors for metabolic disorders. There is increasing evidence that obesity is under control of several cytokines and hormone in the brain. Brain histamine and H3 receptors are important factors for regulating obesity. The results of physiological and pharmacological studies revealed that brain histamine and H3 receptors are involved in the regulation of obesity. In this review, we describe the implication and patent for developing H3 receptor antagonists and their therapeutic potential of obesity.

Keywords: Histamine, obesity, histamine H1 receptors, histamine H3 receptors

Rights & Permissions Print Export Cite as
© 2023 Bentham Science Publishers | Privacy Policy